ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Transmembrane Transporters >Sodium Channel Inhibitor >Levobupivacaine hydrochloride

Levobupivacaine hydrochloride

Levobupivacaine hydrochloride Suppliers list
Company Name: Hebei Ruishun Trade Co.,LTD
Tel: 17052563120
Products Intro: CAS:27262-48-2
Purity:99.50% Package:1kg,25kg,50kg,100kg Remarks:Pharmaceutical
Company Name: Xingtai Haoxun Import and Export Trade Co., Ltd.
Tel: +8617733977883 WhatsApp:+8617733976525
Products Intro: Product Name:Levobupivacaine hydrochloride
Purity:99 Package:1KG;5USD
Company Name: Hebei Miaobian Biotechnology Co., Ltd
Tel: +8617733850068
Products Intro: Product Name:Levobupivacaine hydrochloride
Purity:99.99 Package:1KG;10USD
Company Name: Wuhan Monad Medicine Tech Co.,LTD
Tel: 02768782018
Products Intro: Product Name:Levobupivacaine hydrochloride
Purity:99.99% Package:1KG;8USD
Company Name: Anhui Rencheng Technology Co., Ltd
Tel: 16655163890
Products Intro: Product Name:Levobupivacaine
Purity:>99% Package:1KG;15USD|1KG;90USD

Lastest Price from Levobupivacaine hydrochloride manufacturers

  • Levobupivacaine HCL
  • US $0.00 / KG
  • 2021-04-10
  • CAS:
  • Min. Order: 100g
  • Purity: 98%+
  • Supply Ability: 100kg
Levobupivacaine hydrochloride Basic information
Product Name:Levobupivacaine hydrochloride
Synonyms:TIMTEC-BB SBB001337;(S)-(-)-BUPIVACAINE HCL;(S)-(-)-BUPIVACAINE HYDROCHLORIDE;(S)-(-)-1-N-BUTYL-2',6'-DIMETHYL-2-PIPERIDINCARBOXANILID HYDROCHLORIDE;(S)-(-)-1-BUTYL-2-(2,6-XYLYLCARBAMOYL)-PIPERIDINE HYDROCHLORIDE;s-(-)-1-butyl-2',6'-pipecoloxylidide hydrochloride;(s)-1-butyl-2’,6’-piperidinecarboxamidemonohydrochloride;(s)-1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboxamidemonohydrochloride
Product Categories:API;Inhibitors;Pharmaceutical Raw Materials;Active Pharmaceutical Ingredients
Mol File:27262-48-2.mol
Levobupivacaine hydrochloride Structure
Levobupivacaine hydrochloride Chemical Properties
Melting point 254 °C (dec.)(lit.)
alpha -12.5 º (c=2, water)
storage temp. 2-8°C
solubility H2O: soluble20mg/mL, clear
form powder
color white to beige
optical activity[α]/D -10 to -14°, c = 1.0 in H2O
CAS DataBase Reference27262-48-2(CAS DataBase Reference)
Safety Information
Hazard Codes T+,Xn
Risk Statements 26/27/28-20/21/22-28
Safety Statements 22-36/37/39-45-36/37-53
RIDADR UN 2811 6.1/PG 2
WGK Germany 3
RTECS TK6125000
MSDS Information
Levobupivacaine hydrochloride English
SigmaAldrich English
ACROS English
Levobupivacaine hydrochloride Usage And Synthesis
Uses(S)-(-)-Bupivacaine Hydrochloride is the salt analogue of a local anaesthetic used for epidural and intrathecal anaesthesia.
DescriptionLevobupivacaine was first launched in the US for the production of local anesthesia for surgery and obstetrics and for post-operative pain management. It is the (S)-enantiomer of the long acting, highly potent local anesthetic bupivacaine (Marcaine) that can be prepared by a three step sequence from (S)-pipecolic acid or from (S)-lysine by oxidative deamination and stereospecific ring closure to (S)-pipecolamide core structure. Levobupivacaine exhibits its long-acting local anesthetic effect by blocking neuronal sodium channel ion flow in nerve axons. Clinical studies demonstrated an efficacy and a general profile closely resembling those of the racemic bupivacaine currently in use; however, it produced an enhanced safety profile, in particular substantially reduced (about one-third) cardiotoxicity (less effect on myocardial contractility and QT, prolongation) and CNS depressive side effects. Onset and duration of blockade were also equivalent or even better.
Chemical Propertieswhite crystalline powder
OriginatorChiroscience (UK)
UsesLocal anesthetic; analgesic.
DefinitionChEBI: The monohydrochloride salt of levobupivacaine.
Manufacturing ProcessSynthesis of L-pipecolic acid 2,6-xylidide (Patent US 4,695,576)
130 g of pipecolic acid and 158.6 g of Laevo (+)-tartaric acid are dissolved under stirring in 2 L 95% ethyl alcohol and 125 ml water at 80°C. The solution is allowed to cool to room temperature and after two days the crystallized D-pipecolic-tartrate is separated. The L-pipecolic-tartrate remains in solution. The filtrate is evaporated and dissolved in 5% acetic acid. Finally the solution is treated with Amberlite IR 45* in an ion exchanger. The eluate thus obtained is evaporated and the resulting crystalline residue is dried with potassium hydroxide in vacuo. The product obtained consists of L-pipecolic acid [α]D24 = -26.2°(C = 5, H2O).
4 g of phosphorus pentachloride was added to a suspension of 4 g of Lpipecolic acid hydrochloride in 40 ml acetylchloride. The initial reaction is effected at a temperature of about 35°C under stirring for 2 hours. The chlorination is completed by adding during a time period of about 10 minutes an additional two grams of phosphorus pentachloride and stirring over a further period of 4 hours while maintaining the suspension at a temperature of about 35°C. The resulting L-pipecolic acid chloride hydrochloride is filtered and washed with toluene and acetone. The crystalline residue is then dried in vacuo, m.p. 155°C.
A mixture of 2.7 ml 2,6-dimethylaniline, 4 ml acetone, and 4 ml Nmethylpyrrolidone is gradually added under stirring for 2 hours at 70°C to a suspension of 4 g of L-pipecolic acid chloride hydrochloride. This yields a crystalline product, which is filtered, washed with acetone and dried. This crystalline product is then dissolved in water and the base is precipitated by the addition of ammonia. The base is then extracted by the use of toluene and is recovered by evaporation. The base is recrystallized from a mixture of hexane and ethanol to yield L-pipecolic acid 2,6-xylidide. The melting point of this compound is 129-130°C.
Preparation of L-N-n-butylpipecilic acid 2,6-xylidide may de carried out by analogy with the preparation of L-N-n-propylpipecolic acid 2,6-xylidide (Patent US 5,777,124).
n-Butylbromide and potassium carbonate are added to a solution of L-pipecolic acid 2,6-xylidide dissolved in isopropyl alcohol. Thereafter, 5 ml of water is added to the mixture and the reaction is carried out for 4 hours at 72°C.
To complete the reaction, a further 0.8 ml n-butylbromide are added under continuous stirring and heating for 4 hours. The residue is treated with a mixture of 250 ml toluene and an equal amount of water at 50°C. The toluene layer is separated and washed three times with 100 ml warm water (40°C). A 175 ml portion of the toluene is removed by evaporation and the remainder is stored at +5°C for 6 hours to achieve crude crystalline L-N-n-butylpipecilic acid 2,6-xylidide. The crystalline product is separated by filtration, washed with some cooled toluene and dried at 70°C. Recrystallization may be carried from toluene. This product is dissolved in 100 ml ethanol and neutralized with concentrated hydrochloric acid. Ethanol is removed by evaporation and the hydrochloride product obtained is vacuum dried. Finally the latter is recrystallized from isopropyl alcohol.
Brand nameChirocaine (Purdue).
Therapeutic FunctionLocal anesthetic
Biological FunctionsLevobupivacaine hydrochloride (Chirocaine) is the S-enantiomer of bupivacaine. It too has long action. Animal studies show that it has less CNS and cardiac toxicity than does bupivacaine. It also is slightly more motor sparing than is bupivacaine.
Levobupivacaine hydrochloride Preparation Products And Raw materials
Raw materialsL(+)-Tartaric acid-->Phosphorus pentachloride-->DL-Pipecolinic acid-->AMBERLITE-->1-Bromobutane-->4-Bromo-2,6-dimethylaniline
Tag:Levobupivacaine hydrochloride(27262-48-2) Related Product Information
Levofloxacin hydrochloride 1-AdaMantanethylaMine Formamide 2',6'-Pipecoloxylidide Pipecolamide Levobupivacaine hydrochloride 2-Butoxyethanol Bupivacaine Cyhalofop-butyl Butyl acrylate Bupivacaine hydrochloride Levofloxacin HCL Capsule Butyl acetate Levobupivacaine tert-Butanol Buprofezin Topotecan hydrochloride N,N-Dimethylformamide